Table 4.
Variables | B | Wald | OR | 95% CI (lower-upper) | P | |
---|---|---|---|---|---|---|
Lower | Upper | |||||
Caucasian | −1.542 | 5.609 | 0.214 | 0.06 | 0.767 | 0.018* |
Atrial fibrillation | 1.212 | 6.145 | 3.36 | 1.289 | 8.762 | 0.013* |
Dyslipidemia | 0.822 | 2.707 | 2.274 | 0.855 | 6.053 | 0.1 |
Heart failure | 0.897 | 2.753 | 2.451 | 0.85 | 7.067 | 0.097 |
Lipids | −0.21 | 2.91 | 0.81 | 0.636 | 1.032 | 0.088 |
Changes in ambulation | 1.034 | 4.878 | 2.813 | 1.123 | 7.041 | 0.027* |
Adjusted OR <1 denotes factors that are associated with not having a NIHSS score >7 while OR >1 denotes factors that are associated with having a NIHSS score >7. *Statistical significance (P <0.05) with a 95% CI. Backward stepwise model based on likelihood ratio was applied. Model assumptions were fulfilled. Multicollinearity and interactions among independent variables were checked, and no significant interactions were found. Hosmer-Lemeshow test (P=0.988), Cox and Snell (R2=0.191). OR: Odds ratio, CI: Confidence interval, NIHSS: National Institutes of Health Stroke Scale, rtPA: Recombinant tissue plasminogen activator